The Ethics of Innovation: Disability, Technology, and Reproductive Justice – with Katie Hasson
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson],
Disability Deep Dive
| 07. 24. 2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into the ethical concerns surrounding genetic technologies, the medical vs. social model of disability, and the risk of eugenics in current bioethical practices. Katie also highlights the Center's work in ensuring social justice and equity in biotechnologies, and emphasizing the importance of including disabled voices in policy discussions. The episode concludes with a discussion on the documentary 'Fixed: The Science/Fiction of Human Enhancement,' which examines the impact of biotechnology on the disabled community.
Episode Transcript
Jodi Beckstine (00:01):
Want to talk and explore how disability science and ethics collide in today's tech-driven world? We're diving headfirst into the ethics of innovation on this episode of Disability Deep Dive.
Keith Casebonne (00:38):
Hello, listeners. We are really glad you're here. I'm Keith.
Jodi Beckstine (00:41):
And I'm Jody. Welcome back to Disability Deep Dive.
Keith Casebonne (00:45):
Today's episode is called the...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 09.29.2026
Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...
Artificial Intelligence (AI) has been a major focus of news recently, as it should have been, under the appropriately ridiculous name of Hugging Face, “a leading collaboration platform and community hub for machine learning, artificial intelligence, and data science.” In July, Hugging Face was hacked. The platform itself responded:
Earlier this week, we detected and responded to an intrusion into part of our production infrastructure. This one was different from anything we had handled before in one important way...
By Miryam Naddaf, Nature | 09.21.2026
A wave of epigenetic therapies is offering hope as ways to cure chronic hepatitis B — a lingering liver infection that is caused by the hepatitis B virus (HBV) and affects more than 250 million people around the world. Currently...
By Karen Weintraub, Endpoints News | 09.16.2026
To better understand certain neuropsychiatric disorders, researchers at Stanford University have bred rodents that lack a cortex and hippocampus and then replaced those missing brain cells with human ones.
The altered mice, a scientific first, provided insights that would not...